Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov page as revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T02:15:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the melanoma trial record, including its study details, eligibility criteria, outcomes, and documents, in place of a 403 error screen.
    Difference
    55%
    Check dated 2026-11-11T01:24:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:38:29.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision label changes from v3.7.1 to v3.7.2. The study page itself continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T23:28:13.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:12:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record content. The detailed study information and navigation have been replaced by an error page.
    Difference
    20%
    Check dated 2026-09-22T23:57:18.000Z thumbnail image

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.